arrow
S

Sandra J. van Vliet

i3s - instituto de investigação e inovação em saúde, universidade do porto
H指数:52
被引数:1.5万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

MGL-Based Drug Conjugate: A Novel Glycan-Targeting Strategy for Potential Precision Cancer Therapy

MGL基药物偶联物:一种新型甘露糖基靶向策略用于潜在精准癌症治疗

2026-05-010
OA
Tumor desialylation surpasses anti-PD-L1 checkpoint therapy in restoring anti-tumor immunity in a murine model for colorectal cancer

肿瘤去唾液酸化在恢复结直肠癌小鼠模型中的抗肿瘤免疫方面超越了抗PD-L1检查点疗法

2025-07-070
OAAI
Pancreatic cancer-associated fibroblasts modulate macrophage differentiation via sialic acid-Siglec interactions

胰腺癌相关成纤维细胞通过唾液酸-Siglec相互作用调节巨噬细胞分化

2024-04-0911
OAAI
MUC1 Glycopeptide Vaccine Modified with a GalNAc Glycocluster Targets the Macrophage Galactose C-type Lectin on Dendritic Cells to Elicit an Improved Humoral Response

用GalNAc糖簇修饰的MUC1糖肽疫苗靶向树突状细胞上的巨噬细胞半乳糖C型凝集素,以引起改善的体液反应

2023-06-0615
OAAI
Analysis of the glyco-code in pancreatic ductal adenocarcinoma identifies glycan-mediated immune regulatory circuits
2022-01-1114
OAAI
The Tn antigen promotes lung tumor growth by fostering immunosuppression and angiogenesis via interaction with Macrophage Galactose-type lectin 2 (MGL2)
2021-10-0128
PREAI
α2-3 Sialic acid binding and uptake by human monocyte-derived dendritic cells alters metabolism and cytokine release and initiates tolerizing T cell programming

人单核细胞衍生的树突状细胞结合和摄取 α2-3唾液酸会改变代谢和细胞因子释放,并启动耐受性T细胞编程

2021-06-097
OAAI
Recent advances on smart glycoconjugate vaccines in infections and cancer

智能糖缀合物疫苗在感染和癌症中的研究进展

2021-06-0144
OAAI